FRM
CBST

Fore Research & Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Fore Research & Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-37,900
Closed -$2.51M – 105
2014
Q3 		$2.51M Buy
+37,900
New +$2.49M 0.07% 35

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fore Research & Management's CBST Position: Q4 2014 in Review

Fore Research & Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 37,900 shares — an estimated $2.51M sold.

Fore Research & Management first reported a position in CBST in Q3 2014 and held it in 1 quarter. The position peaked at $2.51M in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Fore Research & Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Fore Research & Management sold 37,900 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $2.51M.
  • Fore Research & Management first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Fore Research & Management's CUBIST PHARMACEUTICALS INC position peaked at $2.51M in Q3 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Fore Research & Management's 13F filing for Q4 2014, filed 11 Feb 2015.